You are currently viewing NAFDAC blacklists Aveo Pharmaceuticals, bans dangerous opioid combination
Share this story

The National Agency for Food and Drug Administration and Control (NAFDAC) has officially blacklisted Aveo Pharmaceuticals Pvt Limited, an India-based pharmaceutical company managed by Vinod Sharma, for its involvement in the illegal production and export of dangerous opioid combinations to West Africa.

A BBC World Service investigation uncovered that Aveo Pharmaceuticals has been manufacturing and exporting unapproved drugs, including Tafrodol and Royal 225, which contain a mix of Tapentadol, a potent opioid, and Carisoprodol, a banned muscle relaxant.

According to Director General of the agency, Prof. Mojisola Christianah Adeyeye, these substances had been linked to addiction, respiratory distress, seizures, and even death.

Advertisement

To order your copy, send a WhatsApp message to +1 317 665 2180

The drugs have reportedly flooded the streets of Ghana, Nigeria, and Côte d’Ivoire, fueling opioid dependence in the region.

She emphasized that it had never approved Tafrodol, Royal 225, or any Tramadol product above 100mg for distribution in Nigeria.

Citing the NAFDAC Act and the Counterfeit and Fake Drugs Act, the agency has taken steps to prevent any future registration of products from Aveo Pharmaceuticals.

A covert investigation revealed that Vinod Sharma personally confirmed large-scale exports of these drugs to West Africa for illegal distribution.

Despite being unlicensed globally, the drugs have become popular street opioids due to their affordability and widespread availability.

Advertisements

NAFDAC has ramped up enforcement measures, collaborating with security agencies to crack down on illicit pharmaceutical sales and prevent the smuggling of these substances through Nigeria’s borders.

The agency reaffirmed its commitment to protecting public health through stringent regulatory practices, inspections, and surveillance to eliminate fake and substandard drugs from circulation.

“The public is urged to avoid unregistered medications and report any suspicious pharmaceutical activities.

“NAFDAC remains steadfast in its mission to safeguard the health of Nigerians,” the agency said.

Do you have an important success story, news, or opinion article to share with with us? Get in touch with us at publisher@thepodiummedia.live-website.com or ademolaakinbola@gmail.com Whatsapp +1 317 665 2180

Join our WhatsApp Group to receive news and other valuable information alerts on WhatsApp.


Share this story
Advertisements
jsay-school

Leave a Reply